Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Ovarian Neoplasms 18Testicular Neoplasms 13Testicular Germ Cell Tumor 9Sarcoma 9Teratoma 6Central Nervous System Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Endodermal Sinus Tumor 5Seminoma 4Ovarian Germ Cell Cancer 4Osteosarcoma 4Liposarcoma 4Kidney Neoplasms 4Hemangiosarcoma 4Fibrosarcoma 4Carcinoma, Embryonal 4Wilms Tumor 3Sarcoma, Synovial 3Sarcoma, Endometrial Stromal 3Neurofibrosarcoma 3Malignant mesenchymal tumor 3Leiomyosarcoma 3Histiocytoma, Malignant Fibrous 3Hemangiopericytoma, Malignant 3Desmoplastic Small Round Cell Tumor 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Pheochromocytoma 2Optic Nerve Glioma 2Neuroblastoma 2

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Sunitinib 1Mental Status and Dementia Tests 1Lapatinib 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Ifosfamide × Gynecologic × Clear all
NCT00470366 2017-11-28

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled 11 charts
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡